Vial filling machine
PRODUCTION IT

The life sciences factory of the future needs digital transformation

We make your production and supply chain Pharma 4.0 ready

Information and automation are key ​​

Changing business models in the pharmaceutical industry are increasing the demand for a flexible and agile production network and supply chain. This requires an integrated information architecture for all manufacturing, supply chain, and support processes.​​

There are two very important assets for managing production: information and automation. Information about material, work force skills and availability, and production assets (machines, equipment, etc.) must be available in real-time. This allows taking accurate decisions that have an immediate impact on production schedules, logistics, quality, and outcomes. ​​

An MES system is the backbone of it all

Without MES and paperless production the complexity of today’s pharmaceutical production can only be managed with significant expenditure and personnel costs.

Changing over to a paperless process has many benefits and involves few risks, if the right method is used.

You can achieve better compliance and efficiency by:

  • Optimization of production processes
  • Improved use of electronic records & signatures (ERES) in compliance with 21CFR11
  • “Review by exception”
  • Production data available across multiple batches and in real time require updated MES versions. 

 


Prepare for Pharma 4.0

Digital transformation of manufacturing processes is a key priority for many life sciences companies. On the road to Pharma 4.0, companies need a manufacturing software that is ready for that journey. The future of the shop floor will be made possible by a highly integrated IT architecture that provides fast processing and availability of data.

This will allow for:

  • Advanced analytics
  • Mobile computing
  • Machine learning
  • Cloud storage

 

…and more

The backbone to orchestrate all these services will be a new generation of MES that allows seamless integration with new technology. NNIT helps to design a Pharma 4.0 manufacturing IT and automation architecture and to make the right decision with their MES investments to be ready for Pharma 4.0.

A modern Production IT does not have to be complicated

We help you to design a Pharma 4.0 manufacturing IT and automation architecture and to make the right decision with your IT investments to be ready for the Factory of the Future.​

We provide a holistic concept that considers both the technical and the pharmaceutical perspective. As an experienced partner, we support you with an end-to-end offering on your journey to a digitalized production.

With the Accelerated Implementation Methodology, the implementation can be completed in half the time of an average MES Implementation.

1. Start with a digital maturity assessment

We provide an in-depth analysis of your current processes, technology, and organization and define your digital roadmap.​

2. Choose the best solution

Our proven system selection method helps you to select the best fitting solutions for your digital roadmap.

3. Implement faster

Let us support your MES projects with our Accelerated Implementation Methodology to reduce implementation risks and costs.

Overview benefits of MES in Pharma

Want to read more?

Discover how you can reap the benefits of a modern MES at reduced cost, time and impact on the organization. This whitepaper shows you how to take the right decisions and apply the appropriate methods when implementing an MES. 

Download here.

Learn on two pages, how the NNIT Accelerated Implementation Methodology can help you to reduce cost, time and risk when implementing an MES.

Download here.

Many life sciences industry companies have implemented their MES solutions during the 1990s and 2000s. Consequently these are now near or at the end of their life cycles. MES providers have either migrated their solutions to new technology platforms or developed entirely new solutions.

The questions facing companies with older generation MES installations are mainly:
• Does the existing MES need to be upgraded?
• When is an upgrade or replacement really needed?
• Which solution will best suit the current and future needs of the business?
• How should the upgrade or replacement be implemented?

Download here.

Read how to set up your migration project and keep control of cost and risk during the whole migration process.

  • Considerations when planning
  • What else is impacted? What are the risks?
  • Business drivers, scoping and business case
  • Migration strategies
  • Data migration

Download here.

The concept of Manufacturing Execution Systems (MES) has been established in the pharmaceutical industry for more than 20 years. But is a system that was designed pre-IoT still right for the journey towards digitalization and Pharma 4.0?

Read what 272 MES and production experts of the life sciences industry think.

Download the full survey report.

Serialization around the world - what you need to know about serialization in each country at a glance:

- Deadlines for Serialization and Aggregation
- Serial Codes
- Governance Reporting

Download here.

Meet our MES expert

In this one-to-one, you will get access to our most valuable learnings about the role of MES in the modern life sciences production landscape.

Discuss your specific situation with Thomas Halfmann, Global Head Production IT and thought leader in pharma MES.

Present your current MES status or issue and learn about possible scenarios.

Book your inspirational talk now.

Orion Arrow Down

Webinar: Why MES is important to fight the crisis!